Gaush Meditech Ltd

Equities

2407

KYG3902N1051

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:06 2024-04-30 am EDT 5-day change 1st Jan Change
19.94 HKD +2.57% Intraday chart for Gaush Meditech Ltd +13.30% -47.25%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Gaush Meditech Ltd. Announces Change in Chief Executive Officer CI
Gaush Meditech Ltd. Proposes Final Ordinary Dividend for the Year Ended December 31, 2023, Payable on 26 July 2024 CI
Gaush Meditech Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Certain Shares of Gaush Meditech Ltd are subject to a Lock-Up Agreement Ending on 12-DEC-2023. CI
Gaush Meditech Registers Rigid Contact Lenses in China MT
Gaush Meditech Ltd(SEHK:2407) added to S&P Global BMI Index CI
Gaush Meditech Swings to H1 Profit MT
Gaush Meditech Ltd Announces Executive Changes CI
Gaush Meditech Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Gaush Meditech to Swing to H1 Profit MT
Gaush Meditech Ltd Provides Group Earnings Guidance for the Six Months Ended June 30, 2023 CI
Certain Shares of Gaush Meditech Ltd are subject to a Lock-Up Agreement Ending on 12-JUN-2023. CI
Gaush Meditech's Controlling Shareholder Repays HK$185 Million Loan Through Over-Allotment Option MT
Gaush Meditech's Loss Widens in 2022 MT
Gaush Meditech Ltd Names Dr. Alexey Nikolaevich Simonov as Chief Technology Officer CI
Gaush Meditech Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Gaush Meditech Subsidiaries Get Exclusive Rights to Distribute Haag-Streit Products in China MT
Gaush Medical Corporation Enters into Distribution Agreement with HAAG-STREIT AG CI
Gaush Meditech to Widen 2022 Loss by Up to 93% MT
Gaush Meditech Ltd. Provides Earnings Guidance for the Year Ended December 31, 2022 CI
Gaush Meditech Bags Deal to Manufacture, Launch Vitrectomy Device in China MT
Gaush Meditech Added to Shanghai-Hong Kong, Shenzhen-Hong Kong Stock Connect MT
Gaush Meditech Gets Marketing Rights for Two Italian Diagnostic Devices MT
Gaush Meditech Makes Multiple C-Level Team Changes MT
Gaush Meditech Ltd Announces Executive Changes CI
Chart Gaush Meditech Ltd
More charts
Gaush Meditech Ltd is a China-based company mainly engaged in ophthalmology medical business. The Company operates in four segments. Proprietary Products segment develops and produces surgical equipment and related supporting software, intra optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables. Distribution segment sells brand ophthalmic medical devices and consumables. Technical Services segment provides warranty service, maintenance service and consumables related to after-sales service. Others segment is mainly engaged in equipment leasing business and intellectual property agency services. The Company's products are widely used in the examination, treatment and correction of ophthalmic subspecialty diseases such as fundus disease, cataract, glaucoma, refraction, optometry, ocular surface, and children's ophthalmology.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
18.45 CNY
Average target price
41.34 CNY
Spread / Average Target
+124.00%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 2407 Stock
  4. News Gaush Meditech Ltd
  5. Gaush Meditech Registers Rigid Contact Lenses in China